346 related articles for article (PubMed ID: 1903091)
41. The enzymology of doxorubicin quinone reduction in tumour tissue.
Cummings J; Allan L; Willmott N; Riley R; Workman P; Smyth JF
Biochem Pharmacol; 1992 Dec; 44(11):2175-83. PubMed ID: 1472082
[TBL] [Abstract][Full Text] [Related]
42. Reconstitution of the brain mixed function oxidase system: purification of NADPH-cytochrome P450 reductase and partial purification of cytochrome P450 from whole rat brain.
Bergh AF; Strobel HW
J Neurochem; 1992 Aug; 59(2):575-81. PubMed ID: 1629729
[TBL] [Abstract][Full Text] [Related]
43. Role of cytochrome P450 in the oxidation of glycerol by reconstituted systems and microsomes.
Clejan LA; Cederbaum AI
FASEB J; 1992 Jan; 6(2):765-70. PubMed ID: 1537467
[TBL] [Abstract][Full Text] [Related]
44. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
John GH; Hasler JA; He YA; Halpert JR
Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
[TBL] [Abstract][Full Text] [Related]
45. In vivo effects of Panax ginseng extracts on the cytochrome P450-dependent monooxygenase system in the liver of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed guinea pig.
Lee HC; Hwang SG; Lee YG; Sohn HO; Lee DW; Hwang SY; Kwak YS; Wee JJ; Joo WH; Cho YK; Moon JY
Life Sci; 2002 Jul; 71(7):759-69. PubMed ID: 12074935
[TBL] [Abstract][Full Text] [Related]
46. Prevention of carbon tetrachloride-induced lipid peroxidation in liver microsomes from dehydroepiandrosterone-pretreated rats.
Aragno M; Tamagno E; Poli G; Boccuzzi G; Brignardello E; Danni O
Free Radic Res; 1994; 21(6):427-35. PubMed ID: 7834057
[TBL] [Abstract][Full Text] [Related]
47. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of cytochrome-P450 reductase by polyols has an electrostatic nature.
Voznesensky AI; Schenkman JB
Eur J Biochem; 1992 Dec; 210(3):741-6. PubMed ID: 1483457
[TBL] [Abstract][Full Text] [Related]
49. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro.
Standeven AM; Wetterhahn KE
Carcinogenesis; 1992 Aug; 13(8):1319-24. PubMed ID: 1499083
[TBL] [Abstract][Full Text] [Related]
50. Differential effect of copper (II) on the cytochrome P450 enzymes and NADPH-cytochrome P450 reductase: inhibition of cytochrome P450-catalyzed reactions by copper (II) ion.
Kim JS; Ahn T; Yim SK; Yun CH
Biochemistry; 2002 Jul; 41(30):9438-47. PubMed ID: 12135366
[TBL] [Abstract][Full Text] [Related]
51. Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol Delta7-reductase system.
Nishino H; Ishibashi T
Arch Biochem Biophys; 2000 Feb; 374(2):293-8. PubMed ID: 10666310
[TBL] [Abstract][Full Text] [Related]
52. Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase.
Arinç E; Celik H
J Biochem Mol Toxicol; 2002; 16(6):286-97. PubMed ID: 12481304
[TBL] [Abstract][Full Text] [Related]
53. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
[TBL] [Abstract][Full Text] [Related]
54. Peroxide-supported in-vitro cytochrome P450 activities in Haemonchus contortus.
Kotze AC
Int J Parasitol; 1999 Mar; 29(3):389-96. PubMed ID: 10333321
[TBL] [Abstract][Full Text] [Related]
55. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
[TBL] [Abstract][Full Text] [Related]
56. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
Ng SF; Waxman DJ
Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
[TBL] [Abstract][Full Text] [Related]
57. The mechanism of stimulation of NADPH oxidation during the mechanism-based inactivation of cytochrome P450 2B1 by N-methylcarbazole: redox cycling and DNA scission.
Shen T; Hollenberg PF
Chem Res Toxicol; 1994; 7(2):231-8. PubMed ID: 8199313
[TBL] [Abstract][Full Text] [Related]
58. Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities.
Bhamre S; Anandatheerathavarada HK; Shankar SK; Boyd MR; Ravindranath V
Arch Biochem Biophys; 1993 Mar; 301(2):251-5. PubMed ID: 8460938
[TBL] [Abstract][Full Text] [Related]
59. Dynamic interactions of rabbit liver cytochromes P450IA2 and P450IIB4 with cytochrome b5 and NADPH-cytochrome P450 reductase in proteoliposomes.
Yamada M; Ohta Y; Bachmanova GI; Nishimoto Y; Archakov AI; Kawato S
Biochemistry; 1995 Aug; 34(32):10113-9. PubMed ID: 7640265
[TBL] [Abstract][Full Text] [Related]
60. Participation of cytochrome P-450 in reductive metabolism of 1-nitropyrene by rat liver microsomes.
Saito K; Kamataki T; Kato R
Cancer Res; 1984 Aug; 44(8):3169-73. PubMed ID: 6430544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]